Diagnosis of hepatic veno-occlusive disease by plasminogen activator inhibitor-1 plasma antigen levels: A prospective analysis in 350 allogeneic hematopoietic stem cell recipients

Pihusch, Markus and Wegner, H. and Goehring, P. and Salat, C. and Pihusch, V. and Hiller, E. and Andreesen, Reinhard and Kolb, H. J. and Holler, Ernst and Pihusch, R. (2005) Diagnosis of hepatic veno-occlusive disease by plasminogen activator inhibitor-1 plasma antigen levels: A prospective analysis in 350 allogeneic hematopoietic stem cell recipients. TRANSPLANTATION, 80 (10). pp. 1376-1382. ISSN 0041-1337,

Full text not available from this repository.

Abstract

Background. Veno-occlusive disease (VOD) is one of the most serious complications following allogeneic hematopoietic stem cell transplantation (HSCT) and is associated with a high mortality. We conducted a large trial in order to investigate the value of plasminogen activator inhibitor-1 (PAI-1) plasma antigen levels in VOD patients as PAI-1 has been described as a possible diagnostic marker of VOID. Methods. In all, 350 stem cell recipients were included in our study. PAI-1 levels were analyzed prior to conditioning therapy and then weekly until eight weeks after HSCT. Transplantation-related complications (TRC) including VOD, microangiopathic hemolytic anemia (MAHA), and graft-versus-host disease (GVHD) were recorded weekly throughout the study. Results. Maximum PAI-1 antigen levels were increased in all patients with VOD (n=15; mean 248 ng/ml; 95% CI 183-314 ng/ml). Maximum PAI-1 levels above 120 ng/ml showed a sensitivity of 100% and a specificity of 30.6% for VOD after HSCT. Conclusion. Our study underlines that maximum PAI-1 plasma antigen levels not exceeding 120 ng/ml have a strong negative predictive value in the diagnosis of VOD and thus represent a helpful non-invasive tool for exclusion of VOD after HSCT.

Item Type: Article
Uncontrolled Keywords: BONE-MARROW-TRANSPLANTATION; VERSUS-HOST-DISEASE; LIVER-DISEASE; ORGAN FAILURE; DEFIBROTIDE; GRAFT; COMPLICATIONS; MICROANGIOPATHY; DISPOSITION; ACTIVATION; hematopoietic stem cell transplantation; plasminogen activator inhibitor-1; veno-occlusive disease
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)
Depositing User: Dr. Gernot Deinzer
Date Deposited: 23 Apr 2021 06:07
Last Modified: 23 Apr 2021 06:07
URI: https://pred.uni-regensburg.de/id/eprint/35407

Actions (login required)

View Item View Item